EASD Berlin 2018 - Abstract

Early impact of liraglutide in routine clinical use (ABCD nationwide liraglutide audit) on cardiovascular risk (UKPDS risk engine). Diabetologia 2018, Vol.61 Supplement1: Abstract 747

C. Walton¹, S. Kassim², R. Harper³, P. McDonald³, U. Brennan³, J. Harding³, T. Htay⁴, R. Nayar⁵, A. Pernet⁶, S. Rowles⁷, K. Adamson⁸, K.Y. Thong⁹, R.E.J. Ryder¹⁰

¹Hull Royal Infirmary, Hull, UK

²Northern HSC, Antrim, UK

³The Ulster Hospital, Dundonald, UK

⁴Kingston Hospital, London, UK

⁵City Hospitals, Sunderland, UK

⁶Kings College Hospital, London, UK

⁷Pennine Acute Hospitals, Manchester, UK

⁸St John’s Hospital, Livingston, UK

⁹School of Medicine and Pharmacology, Perth, Australia

¹⁰City Hospital, Birmingham, UK.

ABCD nationwide liraglutide audit contributors